Original Article

You have full text access to this OnlineOpen article

Diabetes and risk of bladder cancer

Evidence from a case-control study in New England

  1. Todd MacKenzie PhD1,2,†,*,
  2. Michael S. Zens PhD2,
  3. Assiamira Ferrara MD, PhD3,
  4. Alan Schned MD4,
  5. Margaret R. Karagas PhD2

Article first published online: 8 NOV 2010

DOI: 10.1002/cncr.25641

Issue

Cancer

Cancer

Volume 117, Issue 7, pages 1552–1556, 1 April 2011

Additional Information

How to Cite

MacKenzie, T., Zens, M. S., Ferrara, A., Schned, A. and Karagas, M. R. (2011), Diabetes and risk of bladder cancer. Cancer, 117: 1552–1556. doi: 10.1002/cncr.25641

Author Information

  1. 1

    Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire

  2. 2

    Department of Community and Family Medicine, Dartmouth Medical School, Hanover, New Hampshire

  3. 3

    Division of Research, Kaiser Permanente Northern California, Oakland, California

  4. 4

    Department of Pathology, Dartmouth Medical School, Hanover, New Hampshire

  1. †

    Fax: (603) 653-3542

*Section of Clinical Research, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756

Publication History

  1. Issue published online: 18 MAR 2011
  2. Article first published online: 8 NOV 2010
  3. Manuscript Accepted: 22 JUN 2010
  4. Manuscript Revised: 10 JUN 2010
  5. Manuscript Received: 22 MAR 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (117K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maria E Goossens, Frank Buntinx, Steven Joniau, Koen Ackaert, Filip Ameye, Ignace Billiet, Johan Braeckman, Alex Breugelmans, Jochen Darras, Kurt Dilen, Lieven Goeman, Eliane Kellen, Bertrand Tombal, Siska Van Bruwaene, Ben Van Cleyenbreuge, Frank Van der Aa, Kris Vekemans, Hendrik Van Poppel, Maurice P Zeegers, Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium, BMC Urology, 2012, 12, 1, 8

    CrossRef

  2. 2
    Adedayo A. Onitilo, Jessica M. Engel, Ingrid Glurich, Rachel V. Stankowski, Gail M. Williams, Suhail A. Doi, Diabetes and cancer I: risk, survival, and implications for screening, Cancer Causes & Control, 2012, 23, 6, 967

    CrossRef

  3. 3
    Cristina Bosetti, Valentina Rosato, Jerry Polesel, Fabio Levi, Renato Talamini, Maurizio Montella, Eva Negri, Alessandra Tavani, Antonella Zucchetto, Silvia Franceschi, Giovanni Corrao, Carlo La Vecchia, Diabetes Mellitus and Cancer Risk in a Network of Case-Control Studies, Nutrition and Cancer, 2012, 120420081609003

    CrossRef

  4. 4
    Malin H. Faulds, Karin Dahlman-Wright, Metabolic diseases and cancer risk, Current Opinion in Oncology, 2012, 24, 1, 58

    CrossRef

  5. 5
    Chin-Hsiao Tseng, Pioglitazone and bladder cancer in human studies: Is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?, Journal of the Formosan Medical Association, 2012, 111, 3, 123

    CrossRef

  6. 6
    C.-H. Tseng, Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan, Diabetologia, 2011, 54, 8, 2009

    CrossRef

  7. You have free access to this content7
    Emily Jane Gallagher, Derek LeRoith, Diabetes, cancer, and metformin: connections of metabolism and cell proliferation, Annals of the New York Academy of Sciences, 2011, 1243, 1
    Direct Link:
View Full Article (HTML) Get PDF (117K)